top of page

How DISTILL EDC empowered a CRO to compete on a Large Pharma Bid?

Nisha Nair

29 Jan 2025

Challenge


A leading CRO bidding for a massive Phase 3 global study with a top 10 pharma faced a critical requirement: Single Sign-On (SSO) capability for seamless user access. At the time, DISTILL EDC did not offer this feature.


Solution


The CRO, a valued partner and regular user of DISTILL EDC, reached out to us for support. Recognizing the importance of their bid, we acted decisively:

  • Collaborated closely with the CRO to understand their needs.

  • Developed SSO capabilities within an accelerated timeframe of 4 weeks.

  • Delivered the solution on time for their pharma presentation, with no additional cost to the CRO.


Result


  • Enabled the CRO to meet the pharma’s stringent requirements, positioning them as a strong contender.

  • Strengthened trust and collaboration between the CRO and DISTILL.

  • Reinforced DISTILL EDC’s reputation as a flexible, customer-centric partner.


Key Highlights


  • Feature Delivered: Single Sign-On (SSO)

  • Development Time: 4 weeks

  • Cost to CRO: $0


Discover the DISTILL Advantage


We’re committed to helping our partners overcome challenges and achieve success.

Let’s work together to elevate your clinical trials!


✉ Book a Free Demo Today: distill.biz/contact/

Whitepaper

Harnessing AI and Automation in Clinical Data Capture

Whitepaper

Smart Trials, Smarter Decisions: Harnessing EDC for Faster Insights

Whitepaper

Empowering Asia-Pacific Trials with Real-Time Data Intelligence

Whitepaper

Integrating EDC with eSource, CTMS, and ePRO Systems: Transforming Clinical Research Efficiency

Whitepaper

The Role of EDC in Decentralized and Hybrid Trials

Whitepaper

Protocol Amendments & EDC Systems: Managing Cost and Time‑Risk in Clinical Trials

Whitepaper

The Role of EDC in Accelerating Clinical Research Timelines

Whitepaper

Ensuring Regulatory Compliance with DISTILL: GCP, 21 CFR Part 11, and Beyond

Whitepaper

The Future of EDC: How Cloud-Native Platforms Are Transforming Clinical Trials

Whitepaper

Reimagining Clinical Trials with Next-Gen Data Management Platforms

DISTILL Technologies LLC


3701, Churchill Executive Tower
Business Bay, Dubai, UAE

enquiry@svmpharma.com

Privacy statement
 

At DISTILL Technologies, we take data privacy very seriously. As a GDPR-compliant organization, we uphold the highest standards of security, transparency, and integrity across all our products and services. Your trust is our top priority. For more details, please review our Privacy Policy.

In-Blue-72.png
bottom of page